Insider · CIK 0001927058
Josh Mandel-Brehm
Files at PMN (ProMIS Neurosciences Inc.), CAMP (Camp4 Therapeutics Corp). First filing Sep 11, 2025, latest Sep 11, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CAMP: Camp4 Therapeutics Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | Camp4 Therapeutics Corp | $9,999 6,060 shares | +2% | +106% from low-76% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | CAMP Camp4 Therapeutics Corp | POpen-market purchase Common Stock | +6,060 | $1.65 | $9,999 | 278,417 | Sep 11, 2025 |
| Jun 12, 2025 | PMN ProMIS Neurosciences Inc. | AGrant or award Option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Jun 16, 2025 |
| Apr 1, 2025 | CAMP Camp4 Therapeutics Corp | AGrant or award Stock Option (Right to Buy)derivative | +160,000 | $0.00 | $0 | 160,000 | Apr 3, 2025 |
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | CConversion Common Stock | +605 | - | - | 272,357 | Oct 15, 2024 |
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | CConversion Series B Preferred Stockderivative | -6,791 | - | - | 0 | Oct 15, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.